Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact firstname.lastname@example.org.
SOURCE Research and Markets
DUBLIN, Ireland, October 4, 2013 /PRNewswire/ --
Research and Markets ( http://www.researchandmarkets.com/research/cvknrc/global_dna) has announced the addition of the "Global DNA Sequencing Equipment and Services Market 2012-2016" report to their offering.
The analysts forecast the Global DNA Sequencing Equipment and Services market to grow at a CAGR of 20.86 percent over the period 2012-2016. One of the key factors contributing to this market growth is the significant advancements witnessed in R&D divisions. The Global DNA Sequencing Equipment and Services market has also been witnessing an increasing number of DNA sequencing projects. However, difficulties faced by small vendors could pose a challenge to the growth of this market.
The key vendors dominating this space include Agilent Technologies Inc., Illumina Inc., Life Technologies Corp., Pacific Biosciences of California Inc., and Roche Holding AG.
Commenting on the report, an analyst from the team said: One of the main trends witnessed in the Global DNA Sequencing Equipment and Services market is increase in number of DNA sequencing projects. The Global DNA Sequencing Equipment and Services market has recently witnessed a significant increase in the number of projects funded by the leading vendors. For instance, Illumina and Partners HealthCare System Inc. announced a strategic alliance in September 2012, in order to offer infrastructure and networking tools for the interpretation and reporting process on genetic sequencing data. Moreover, Hoffmann-La Roche Ltd. and SoftGenetics LLC signed a co-promotion agreement in May 2012 for a new sequencing software tool. Roche and PerkinElmer Inc. announced a new supply agreement in May 2011 for the distribution of the NimbleGen CGX microarray workflow. In addition, Pacific Biosciences announced collaboration in July 2012, with Imec, a Belgium-based nanoelectronics research center focusing on the improvement of innovative microchips for multiplexed single-molecule genetic analysis.
According to the report, one of the main factors driving the market is success of HGP. The HGP is an international scientific research project to regulate DNA sequences of the human body and to map the genes. The success of the HGP has led to a better understanding of human evolution. The effect of the HGP can help in the genotyping of specific viruses to direct suitable cure, identification of oncogenes and mutations in cancer, development of forensic applied sciences, and risk valuation.
Further, the report states that one of the main challenges is low adoption of genomic technology. Adoption of genomic technology remains low compared to other sequence analysis technologies, especially among large biotechnology companies. Researchers still have doubts over the advantages of genomic technology, mainly because of a few instances of failure during genomic research programs.
For more information visit http://www.researchandmarkets.com/research/cvknrc/global_dna
About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
©2012 PR Newswire. All Rights Reserved.